Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target

Bladder cancer (BC) is the ninth most malignant tumor worldwide. Some BC patients will develop muscle‐invasive BC (MIBC), which has a 5‐year survival rate of approximately 60% due to metastasis. As such, there is an urgent need for novel therapeutic and diagnostic targets for MIBC. Analysis of novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Yasutaka, Kato, Mayuko, Arai, Takayuki, Sanada, Hiroki, Uchida, Akifumi, Misono, Shunsuke, Sakamoto, Shinichi, Komiya, Akira, Ichikawa, Tomohiko, Seki, Naohiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717764/
https://www.ncbi.nlm.nih.gov/pubmed/31199049
http://dx.doi.org/10.1002/1878-0261.12532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717764/
https://www.ncbi.nlm.nih.gov/pubmed/31199049
http://dx.doi.org/10.1002/1878-0261.12532

Ejemplares similares